EQT's Liu Sees PE Opportunities in Health-Care Data Industry

The video discusses a Swedish private equity firm's recent large cap exit and its investment strategies in healthcare. It highlights the digitalization of healthcare, focusing on Press Ganey's patient survey services and Certara's bio simulation technology. The firm emphasizes its investment in healthcare data and product companies, leveraging its experience and advisor network. The video also explores market opportunities, competition, and the trend of LPs co-investing with GPs.

What factors does the company consider when checking their value creation path?

How has the company evolved from its original purpose as a patient survey company?

What unique capabilities does Certara offer in the pharmaceutical technology space?

What are the two sectors that the firm is currently focusing on for future investments in healthcare?

What trends have been observed in the healthcare data space regarding deal-making?